Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3065 |
|
Actual shortage: | 232 (8%) | |
Anticipated shortage: | 15 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2809 (92%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
30 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-IBUPROFEN | 200MG | TABLET | Resolved | 2022-02-11 | 2022-05-14 | 154762 |
APO-ACYCLOVIR | 200MG | TABLET | Resolved | 2022-04-08 | 2022-04-13 | 158339 |
APO-ACEBUTOLOL | 200MG | TABLET | Resolved | 2022-06-17 | 2022-09-23 | 162899 |
APO-ACYCLOVIR | 200MG | TABLET | Resolved | 2022-11-14 | 2023-02-09 | 174636 |
APO-ALLOPURINOL | 200MG | TABLET | Resolved | 2022-12-02 | 2023-01-26 | 176942 |
APO-ALLOPURINOL | 200MG | TABLET | Resolved | 2022-12-09 | 2023-01-26 | 177615 |
APO-QUETIAPINE XR | 200MG | TABLET (EXTENDED-RELEASE) | Resolved | 2022-12-09 | 2022-12-16 | 177672 |
APO-ALLOPURINOL | 200MG | TABLET | Resolved | 2023-02-16 | 2023-05-26 | 185028 |
APO-ACEBUTOLOL | 200MG | TABLET | Resolved | 2023-02-23 | 2023-03-16 | 185448 |
APO-CELECOXIB | 200MG | CAPSULE | Resolved | 2023-02-23 | 2023-03-02 | 185471 |
APO-LABETALOL | 200MG | TABLET | Resolved | 2023-02-23 | 2023-03-02 | 185489 |
APO-AMIODARONE TABLETS | 200MG | TABLET | Resolved | 2023-03-23 | 2023-05-06 | 187727 |
APO-ALLOPURINOL | 200MG | TABLET | Resolved | 2023-03-30 | 2023-05-26 | 188424 |
APO-LABETALOL | 200MG | TABLET | Resolved | 2023-07-13 | 2023-07-21 | 198511 |
APO-AMIODARONE TABLETS | 200MG | TABLET | Resolved | 2023-09-15 | 2023-09-28 | 204408 |
APO-ALLOPURINOL | 200MG | TABLET | Resolved | 2023-11-06 | 2024-01-26 | 209369 |
APO-TOPIRAMATE | 200MG | TABLET | Resolved | 2023-11-10 | 2024-01-05 | 209948 |
APO-LABETALOL | 200MG | TABLET | Resolved | 2023-11-10 | 2024-01-05 | 209964 |
APO-ACEBUTOLOL | 200MG | TABLET | Resolved | 2023-11-17 | 2023-12-15 | 210707 |
APO-ALLOPURINOL | 200MG | TABLET | Resolved | 2023-12-15 | 2024-01-26 | 213584 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-AMOXI SUGAR FREE | 125MG | POWDER FOR SUSPENSION | Discontinued | 2018-09-07 | 2018-09-15 | 60249 |
APO NAPROXEN TAB 125MG | 125MG | TABLET | Discontinued | 2018-09-08 | 2019-08-08 | 60663 |
APO-HYDROMORPHONE CR | 12MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110962 |
APO-NIZATIDINE | 150MG | CAPSULE | Discontinued | 2017-03-13 | 2017-03-13 | 1127 |
APO-SULIN TAB 150MG | 150mg | tablet | Discontinued | 2017-03-13 | 2017-03-13 | 1186 |
APO-CLINDAMYCIN | 150MG | CAPSULE | To be discontinued | 2018-09-07 | 2018-12-28 | 60396 |
APO-IRBESARTAN | 150MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60536 |
APO-LAMIVUDINE | 150MG | TABLET | Discontinued | 2018-09-07 | 2019-07-13 | 60557 |
APO-RANITIDINE TABLET 150MG | 150MG | TABLET | Discontinued | 2018-09-08 | 2019-02-13 | 60723 |
APO-RANITIDINE TABLET 150MG | 150MG | TABLET | Discontinued | 2018-09-08 | 2018-12-28 | 60726 |
APO-RANITIDINE TABLET 150MG | 150MG | TABLET | Discontinued | 2019-01-02 | 2019-01-09 | 70810 |
ACID REDUCER | 150MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71210 |
APO-IRBESARTAN | 150MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71234 |
APO-CLINDAMYCIN | 150MG | CAPSULE | Discontinued | 2019-11-11 | 2019-11-11 | 98363 |
APO-OXAZEPAM | 15MG | TABLET | To be discontinued | 2018-09-08 | 2018-09-08 | 60678 |
APO-TEMAZEPAM | 15MG | CAPSULE | Discontinued | 2018-10-23 | 2019-01-14 | 65477 |
APO-PINDOL TAB 15MG | 15MG | TABLET | Discontinued | 2022-02-09 | 2022-12-09 | 154574 |
APO-SOTALOL | 160MG | TABLET | Discontinued | 2017-03-31 | 2018-02-05 | 4971 |
APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60313 |
APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60316 |